Biologic dose tapering in #axialspondyloarthritis in 52% of patients if criteria are met (BASDAI)< 40, physician global score< 40 and no signs of disease activity the previous year, escalation to previous dose if there is a flare @RheumNow #ACR21 Abst#0364 https://t.co/4GntJ6jS11
Links:
Dose Tapering of TNF Inhibitors in Patients with Axial Spondyloarthritis in Rou…
https://bit.ly/3nX7ftq
06-11-2021